Live feed16:16:32·1189dSECFilingvia QuantisnowCatalyst Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.CBIO· Crescent Biopharma Inc.Health CareOriginal source